Treatment of Urinary Incontinence/Overactive Bladder After Hysterectomy
Begin with conservative behavioral interventions as first-line therapy—specifically supervised pelvic floor muscle training (PFMT) for stress incontinence and bladder training for urgency symptoms—before considering any pharmacologic or surgical options, as these have strong evidence with number needed to treat of 2 and success rates exceeding 50-70%. 1
Initial Diagnostic Evaluation
Post-hysterectomy urinary symptoms require careful characterization to guide treatment:
- Perform a detailed history focusing on the type of incontinence (stress vs. urgency vs. mixed), frequency and severity of episodes, impact on quality of life, and timing relative to hysterectomy 2
- Conduct physical examination with a comfortably full bladder, including pelvic exam and stress testing to document involuntary urine loss coincident with coughing or Valsalva maneuver 2
- Consider urodynamic testing in this non-index population given the history of prior pelvic surgery, as post-hysterectomy patients warrant additional evaluation per AUA/SUFU guidelines 2
The AUA/SUFU guidelines specifically identify prior pelvic surgery (including hysterectomy) as an indication for urodynamic studies, as these can change management in 42-62% of cases and identify voiding dysfunction in 19% of patients 2.
Treatment Algorithm Based on Incontinence Type
For Stress Urinary Incontinence (SUI)
First-line: Conservative Management
- Initiate supervised PFMT immediately, as this is more than 5 times as effective as no treatment with 50-70% symptom improvement 1
- Add weight loss programs if the patient is obese (number needed to treat = 4) 1
- Avoid systemic pharmacologic therapy for stress incontinence, as it is completely ineffective 1
Second-line: Surgical Options (if conservative measures fail after 3-6 months)
- For patients with hypermobile urethra without intrinsic sphincter deficiency: Consider retropubic urethropexy (Burch procedure) with 81% cure rates at 12-23 months, or mid-urethral synthetic slings with 84% cure rates 2, 3
- For patients with intrinsic sphincter deficiency: Recommend sling procedures (pubovaginal sling or retropubic tension-free vaginal tape preferred over transobturator tape) 3
- For patients with significantly decreased urethral mobility: Consider periurethral bulking injections, retropubic sling, or in severe cases, artificial sphincter 3
Post-hysterectomy stress incontinence is particularly common, with hysterectomy associated with 2.40 times higher likelihood of stress incontinence beyond 10 years 4.
For Urgency Incontinence/Overactive Bladder (OAB)
First-line: Behavioral Interventions
- Implement bladder training with scheduled toileting every 2 hours during waking hours and every 4 hours at night (number needed to treat = 2) 5, 1
- Regulate fluid intake: Encourage high daytime fluids but decrease evening intake 5
- Eliminate bladder irritants including caffeine, alcohol, and highly seasoned foods 5
Second-line: Pharmacologic Management (only after 2-4 weeks of unsuccessful behavioral therapy)
- Add antimuscarinic agents such as tolterodine 2 mg twice daily, which is FDA-approved for overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency 6
- Select anticholinergics based on tolerability and cost rather than efficacy, as they show similar effectiveness 1
- Exercise caution in elderly patients due to high risk of cognitive impairment, falls, and anticholinergic burden 5
Hysterectomy is associated with 1.41 times higher likelihood of overactive bladder within 10 years 4.
For Mixed Incontinence
- Combine supervised PFMT plus bladder training together as the primary initial approach 1
- Address the predominant symptom first when selecting additional therapies 1
Special Considerations for Post-Hysterectomy Patients
The neurologic etiology of post-hysterectomy urinary dysfunction is well-established, with 70-85% experiencing some dysfunction initially, though spontaneous recovery occurs within 6-12 months in many cases 7. However, long-term stress incontinence persists in 40% of cases and is particularly challenging to manage 7.
For refractory cases beyond 3 months of combined therapy:
- Refer to urology for consideration of advanced therapies 5
- Consider neuromodulation: Sacral nerve stimulation for refractory overactive bladder or superior hypogastric plexus stimulation for bladder underactivity 7
- Evaluate for voiding dysfunction: If elevated post-void residual volumes are present, consider intermittent self-catheterization, timed toileting, or urethral sphincter relaxants 3
Critical Pitfalls to Avoid
- Never skip behavioral interventions and jump directly to medications or surgery, as bladder training and PFMT have strong evidence and fewer adverse effects 5, 1
- Do not use indwelling catheters for managing incontinence, as they increase infection risk; intermittent catheterization is preferred if needed 5
- Avoid retropubic urethropexy alone in cases of total sphincter failure or intrinsic sphincter deficiency, as it will not relieve incontinence; sling procedures are required 8
- Do not perform operations to increase bladder outlet resistance if incremental bladder pressure response to filling is present on urodynamics 8